\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\)\\ \\ ap\\ knee\\:\\ chondrocalcinosis\\ demonstrated\\ by\\ wedge\\ shaped\\ calcification\\ seen\\ in\\ the\\ fibrocartilaginous\\ menisci\\ and\\ curvilinear\\ calcification\\ of\\ the\\ hyaline\\ cartilage\\ seen\\ best\\ on\\ the\\ medial\\ aspect\\ of\\ lateral\\ femoral\\ condyle\\.\\ calcification\\ of\\ the\\ cruciate\\ ligaments\\ is\\ also\\ appreciated\\.\\ the\\ medial\\ and\\ lateral\\ tibio\\-femoral\\ joint\\ spaces\\ remain\\ preserved\\.\ \(0\)\
\-\ 2\\.\\)\\ lateral\\ knee\\:\\ the\\ femoro\\-patellar\\ joint\\ space\\ is\\ preserved\\ with\\ minimal\\ subchondral\\ sclerosis\\.\\ curvilinear\\ calcification\\ in\\ the\\ hyaline\\ cartilage\\ of\\ the\\ medial\\ and\\ lateral\\ femoral\\ condyles\\ and\\ \\ the\\ calcified\\ menisci\\ are\\ also\\ seen\\.\ \(0\)\
\-\ 3\\.\\)\\ left\\ hip\\:\\ uniform\\ narrowing\\ of\\ joint\\ space\\ with\\ axial\\ migration\\ of\\ femoral\\ head\\.\\ numerous\\ subchondral\\ cysts\\.mild\\ degenerative\\ change\\ with\\ osteophyte\\ formation\ \(0\)\
\-\ 4\\.\\)\\ right\\ hip\\:\\ joint\\ space\\ preserved\\.\\ calcinosis\\ of\\ femoral\\ hyaline\\ cartilage\\.\\ sclerotic\\ changes\\ in\\ acetabulum\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ crystal\\ deposition\\ disease\\ \\(cppd\\)\\ \\(pseudogout\\)\ \(0\)\
\-\ 1\\.\\)\\ cation\\ disease\ \(0\)\
\-\ 2\\.\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ 3\\.\\)\\ cartilage\\ degeneration\\ from\\ unknown\\ cause\\.\ \(0\)\
\-\ 61yo\\ caucasian\\ male\\ with\\ 4\\-5\\ year\\ history\\ of\\ intermittent\\ acute\\ episodes\\ of\\ swollen\\,\\ red\\,\\ painful\\ knees\\ and\\ left\\ hip\\.\\ episodes\\ of\\ pain\\ last\\ 1\\-2\\ weeks\\ and\\ are\\ usually\\ relieved\\ with\\ nsaids\\.\ \(0\)\
\-\ cppd\\ may\\ produce\\ the\\ clinical\\ symtoms\\ and\\ findings\\ of\\ pseudogout\\ and\\ occurs\\ usually\\ in\\ persons\\ \\ over\\ age\\ 50\\ with\\ no\\ gender\\ preference\\.\\ some\\ studies\\ show\\ its\\ prevalence\\ to\\ 3\\-5\\%\\ of\\ the\\ adult\\ population\\ as\\ demonstrated\\ by\\ calcium\\ pyrophosphate\\ dihydrate\\ deposits\\ in\\ the\\ knee\\ joint\\ making\\ it\\ the\\ most\\ common\\ crystal\\ arthropathy\\.\\ however\\,\\ it\\ is\\ estimated\\ that\\ there\\ is\\ only\\ one\\ symptomatic\\ patient\\ for\\ every\\ 2\\-3\\ patients\\ with\\ gouty\\ arthritis\\.\ \(0\)\
\-\ when\\ chondrocalcinosis\\ is\\ identified\\ the\\ differential\\ diagnosis\\ is\\ relatively\\ short\\.\\ it\\ is\\ essentially\\ the\\ 3\\ c\\'s\\ 1\\)\\ cation\\ disease\\,\\ 2\\)\\ crystal\\ deposition\\ disease\\,\\ 3\\)\\ cartilage\\ degeneration\\ from\\ unknown\\ cause\\.\ \(0\)\
\-\ cation\\ diseases\\ includes\\ 1\\)\\ hyperparathyroidism\\,\\ 2\\)\\ hemochromatosis\\,\\ 3\\)\\ wilson\\'s\\ disease\\.\\ approximately\\ 30\\-50\\%\\ of\\ patients\\ with\\ hyperparathyroidism\\ or\\ hemochromatosis\\ have\\ arthropathy\\ secondary\\ to\\ calcium\\ pyrophosphate\\ deposits\\.\\ it\\ is\\ thought\\ that\\ high\\ concentrations\\ of\\ these\\ ions\\ inhibits\\ the\\ normal\\ hydrolysis\\ of\\ calcium\\ pyrophosphate\\ leading\\ to\\ crystal\\ formation\\ and\\ deposition\\.\\ wilson\\'s\\ disease\\ is\\ rare\\ and\\ the\\ neurologic\\ symptoms\\ far\\ outweigh\\ the\\ joint\\ manifestations\\ but\\ it\\ is\\ associated\\ with\\ chondrocalcinosis\\.\ \(0\)\
\-\ crystal\\ deposition\\ disease\\ included\\ gout\\ \\(sodium\\ monourate\\)\\ or\\ pseudogout\\ \\(calcium\\ pyrophosphate\\)\\ crystals\\ in\\ the\\ joint\\ space\\.\\ the\\ crystals\\ are\\ irritating\\ and\\ clinically\\ both\\ of\\ these\\ diseases\\ can\\ present\\ similarly\\.\\ identifying\\ an\\ associated\\ effusion\\ and\\ chondrocalcinosis\\ makes\\ cppd\\ more\\ likely\\.\\ examination\\ of\\ the\\ synovial\\ fluid\\ confirms\\ the\\ diagnosis\\.\\ under\\ polarized\\ light\\ the\\ calcium\\ pyrophosphate\\ crystals\\ are\\ short\\ blunt\\ rods\\ rhomboids\\ and\\ cuboids\\ and\\ have\\ weakly\\ positive\\ birefringence\\.\\ the\\ sodium\\ urate\\ crystals\\ are\\ needle\\ shaped\\ and\\ show\\ strongly\\ negative\\ birefringence\\.\\ cppd\\ most\\ commonly\\ affects\\ the\\ knee\\,\\ wrist\\ pubic\\ symphysis\\.\\ in\\ a\\ patient\\ with\\ cppd\\ at\\ least\\ one\\ of\\ these\\ areas\\ will\\ be\\ affected\\.\\ a\\ presumptive\\ radiologic\\ diagnosis\\ may\\ be\\ made\\ if\\ two\\ or\\ more\\ skeletal\\ areas\\ show\\ chondrocalcinosis\\.\ \(0\)\
\-\ the\\ other\\ forms\\ of\\ cartilage\\ degeneration\\ are\\ often\\ associated\\ with\\ calcium\\ hydroxyapatite\\.\\ these\\ crystals\\ are\\ deposited\\ in\\ the\\ tendons\\ and\\ joint\\ soft\\ tissues\\.\\ it\\ is\\ associated\\ with\\ unusually\\ high\\ levels\\ of\\ collagenase\\.\ \(0\)\
\-\ ochronosis\\ is\\ another\\ disease\\ associated\\ with\\ calcium\\ hydroxyapatite\\.\\ the\\ cartilage\\ destruction\\ comes\\ from\\ the\\ underlying\\ metabolic\\ disorder\\ absent\\ homogentisic\\ acid\\ oxidase\\.\\ this\\ excess\\ homogentisic\\ acid\\ is\\ deposited\\ in\\ the\\ cartilage\\.\\ it\\ is\\ associated\\ with\\ osteoporosis\\,\\ multiple\\ level\\ disc\\ degeneration\\,\\ loss\\ of\\ joint\\ space\\,\\ and\\ intra\\-articular\\ loose\\ bodies\\.\\ the\\ spine\\ is\\ most\\ frequently\\ affected\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cartilage\\:\\ 0\\.2454772620941667\ \(0\)\
\-\ calcium\\:\\ 0\\.23382640317487166\ \(0\)\
\-\ crystal\\:\\ 0\\.2288905127533894\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.22737747854279192\ \(0\)\
\-\ crystals\\:\\ 0\\.2016055623319539\ \(0\)\
\-\ the\\:\\ 0\\.20017009583167622\ \(0\)\
\-\ joint\\:\\ 0\\.19191539183714582\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.19074209396115785\ \(0\)\
\-\ cppd\\:\\ 0\\.17924118930460878\ \(0\)\
\-\ deposition\\:\\ 0\\.1632453176435968\ \(0\)\
\-\ cation\\:\\ 0\\.1552546345806809\ \(0\)\
\-\ of\\:\\ 0\\.13298909429263778\ \(0\)\
\-\ is\\:\\ 0\\.1329322970354569\ \(0\)\
\-\ pseudogout\\:\\ 0\\.12965699317014576\ \(0\)\
\-\ disease\\:\\ 0\\.1222542373831114\ \(0\)\
\-\ degeneration\\:\\ 0\\.12037550353031974\ \(0\)\
\-\ femoral\\:\\ 0\\.12025841019122739\ \(0\)\
\-\ hyaline\\:\\ 0\\.11986496711265208\ \(0\)\
\-\ it\\:\\ 0\\.1159543490267986\ \(0\)\
\-\ and\\:\\ 0\\.11367745213042074\ \(0\)\
\-\ space\\:\\ 0\\.10770293348160082\ \(0\)\
\-\ deposited\\:\\ 0\\.10350308972045393\ \(0\)\
\-\ homogentisic\\:\\ 0\\.10350308972045393\ \(0\)\
\-\ associated\\:\\ 0\\.10233858077900485\ \(0\)\
\-\ preserved\\:\\ 0\\.10189218344871968\ \(0\)\
\-\ birefringence\\:\\ 0\\.09890272785783431\ \(0\)\
\-\ knee\\:\\ 0\\.09278256979693596\ \(0\)\
\-\ calcification\\:\\ 0\\.09241597415363043\ \(0\)\
\-\ with\\:\\ 0\\.08871237016319206\ \(0\)\
\-\ are\\:\\ 0\\.08595546644015062\ \(0\)\
\-\ dihydrate\\:\\ 0\\.08317398676093261\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.08317398676093261\ \(0\)\
\-\ menisci\\:\\ 0\\.077960184240225\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.07737821624695033\ \(0\)\
\-\ wilson\\:\\ 0\\.0757924928475973\ \(0\)\
\-\ sodium\\:\\ 0\\.07530961621248176\ \(0\)\
\-\ hip\\:\\ 0\\.07457558531173628\ \(0\)\
\-\ deposits\\:\\ 0\\.07356063980392474\ \(0\)\
\-\ these\\:\\ 0\\.07309596231462467\ \(0\)\
\-\ in\\:\\ 0\\.07245226416015162\ \(0\)\
\-\ acid\\:\\ 0\\.06721130153274808\ \(0\)\
\-\ curvilinear\\:\\ 0\\.06698208387034842\ \(0\)\
\-\ arthropathy\\:\\ 0\\.06549545182915455\ \(0\)\
\-\ lateral\\:\\ 0\\.06423929693057615\ \(0\)\
\-\ medial\\:\\ 0\\.06319276734181231\ \(0\)\
\-\ subchondral\\:\\ 0\\.061936728173716905\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.06164947515004863\ \(0\)\
\-\ show\\:\\ 0\\.06162964208886671\ \(0\)\
\-\ diseases\\:\\ 0\\.05946330009046581\ \(0\)\
\-\ episodes\\:\\ 0\\.059117713321897566\ \(0\)\
\-\ short\\:\\ 0\\.055629026236935844\ \(0\)\
\-\ shaped\\:\\ 0\\.05407235762526606\ \(0\)\
\-\ affected\\:\\ 0\\.05323153684440342\ \(0\)\
\-\ 61yo\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ ions\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ hydrolysis\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ monourate\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ polarized\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ rhomboids\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ cuboids\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ collagenase\\:\\ 0\\.05175154486022696\ \(0\)\
\-\ formation\\:\\ 0\\.05131021451352667\ \(0\)\
\-\ most\\:\\ 0\\.050524211392116686\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05032642030328624\ \(0\)\
\-\ irritating\\:\\ 0\\.04945136392891716\ \(0\)\
\-\ oxidase\\:\\ 0\\.04945136392891716\ \(0\)\
\-\ unknown\\:\\ 0\\.04904379821355245\ \(0\)\
\-\ fibrocartilaginous\\:\\ 0\\.04781935958600154\ \(0\)\
\-\ symtoms\\:\\ 0\\.04781935958600154\ \(0\)\
\-\ weakly\\:\\ 0\\.04655347867192602\ \(0\)\
\-\ urate\\:\\ 0\\.04655347867192602\ \(0\)\
\-\ ochronosis\\:\\ 0\\.04655347867192602\ \(0\)\
\-\ seen\\:\\ 0\\.04570523754536502\ \(0\)\
\-\ persons\\:\\ 0\\.04551917865469173\ \(0\)\
\-\ preference\\:\\ 0\\.04551917865469173\ \(0\)\
\-\ outweigh\\:\\ 0\\.04551917865469173\ \(0\)\
\-\ 50\\:\\ 0\\.045199572578263576\ \(0\)\
\-\ cause\\:\\ 0\\.04409100364966521\ \(0\)\
\-\ areas\\:\\ 0\\.043941121834773854\ \(0\)\
\-\ inhibits\\:\\ 0\\.04388717431177612\ \(0\)\
\-\ calcinosis\\:\\ 0\\.04262129339770059\ \(0\)\
\-\ concentrations\\:\\ 0\\.04262129339770059\ \(0\)\
\-\ unusually\\:\\ 0\\.04262129339770059\ \(0\)\
\-\ rods\\:\\ 0\\.04113291556661911\ \(0\)\
\-\ usually\\:\\ 0\\.040744315053541556\ \(0\)\
\-\ condyles\\:\\ 0\\.040712505176187797\ \(0\)\
\-\ gouty\\:\\ 0\\.040712505176187797\ \(0\)\
\-\ similarly\\:\\ 0\\.039954989037550695\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03977583173435761\ \(0\)\
\-\ symphysis\\:\\ 0\\.0392868124491565\ \(0\)\
\-\ from\\:\\ 0\\.03855670101587109\ \(0\)\
\-\ presumptive\\:\\ 0\\.038412324244877984\ \(0\)\
\-\ gender\\:\\ 0\\.03789624642379865\ \(0\)\
\-\ excess\\:\\ 0\\.03789624642379865\ \(0\)\
\-\ comes\\:\\ 0\\.03720073029239369\ \(0\)\
\-\ one\\:\\ 0\\.037055853954279974\ \(0\)\
\-\ high\\:\\ 0\\.03678321878325427\ \(0\)\
\-\ cruciate\\:\\ 0\\.03658124880294478\ \(0\)\
\-\ pubic\\:\\ 0\\.03658124880294478\ \(0\)\
\-\ patients\\:\\ 0\\.036409144624769865\ \(0\)\
\-\ osteophyte\\:\\ 0\\.03602280376332527\ \(0\)\
\-\ identifying\\:\\ 0\\.035848237860921756\ \(0\)\
\-\ more\\:\\ 0\\.03553879290840136\ \(0\)\
\-\ acetabulum\\:\\ 0\\.03551443898788684\ \(0\)\
\-\ prevalence\\:\\ 0\\.035354627174931076\ \(0\)\
\-\ tendons\\:\\ 0\\.034900549361083874\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.03448013897065256\ \(0\)\
\-\ blunt\\:\\ 0\\.034346651771964366\ \(0\)\
\-\ migration\\:\\ 0\\.03421623351800614\ \(0\)\
\-\ relieved\\:\\ 0\\.033964061149573226\ \(0\)\
\-\ wedge\\:\\ 0\\.033842057647508875\ \(0\)\
\-\ uniform\\:\\ 0\\.033842057647508875\ \(0\)\
\-\ or\\:\\ 0\\.03377296463517057\ \(0\)\
\-\ knees\\:\\ 0\\.03372262283201546\ \(0\)\
\-\ forms\\:\\ 0\\.03372262283201546\ \(0\)\
\-\ loose\\:\\ 0\\.03372262283201546\ \(0\)\
\-\ estimated\\:\\ 0\\.03360565076637404\ \(0\)\
\-\ synovial\\:\\ 0\\.03326854501816826\ \(0\)\
\-\ manifestations\\:\\ 0\\.03316048567108438\ \(0\)\
\-\ affects\\:\\ 0\\.03316048567108438\ \(0\)\
\-\ far\\:\\ 0\\.03295035260393061\ \(0\)\
\-\ remain\\:\\ 0\\.03274772591457727\ \(0\)\
\-\ essentially\\:\\ 0\\.03274772591457727\ \(0\)\
\-\ ligaments\\:\\ 0\\.03264906352871935\ \(0\)\
\-\ gout\\:\\ 0\\.03264906352871935\ \(0\)\
\-\ may\\:\\ 0\\.03256968603727588\ \(0\)\
\-\ strongly\\:\\ 0\\.03255208776222721\ \(0\)\
\-\ produce\\:\\ 0\\.03245674191793993\ \(0\)\
\-\ makes\\:\\ 0\\.03245674191793993\ \(0\)\
\-\ making\\:\\ 0\\.032362972110388716\ \(0\)\
\-\ have\\:\\ 0\\.032331727320214304\ \(0\)\
\-\ nsaids\\:\\ 0\\.03166388021826342\ \(0\)\
\-\ condyle\\:\\ 0\\.03142244190070565\ \(0\)\
\-\ every\\:\\ 0\\.031344193153985504\ \(0\)\
\-\ swollen\\:\\ 0\\.031267009049136735\ \(0\)\
\-\ confirms\\:\\ 0\\.031267009049136735\ \(0\)\
\-\ population\\:\\ 0\\.030615893959903592\ \(0\)\
\-\ red\\:\\ 0\\.030480817478617816\ \(0\)\
\-\ also\\:\\ 0\\.03044293910608374\ \(0\)\
\-\ radiologic\\:\\ 0\\.030156560986630124\ \(0\)\
\-\ needle\\:\\ 0\\.030031875875347804\ \(0\)\
\-\ least\\:\\ 0\\.02990987237328345\ \(0\)\
\-\ adult\\:\\ 0\\.02984984065758612\ \(0\)\
\-\ destruction\\:\\ 0\\.02950240898929716\ \(0\)\
\-\ spaces\\:\\ 0\\.029446517461383537\ \(0\)\
\-\ skeletal\\:\\ 0\\.029336359743942834\ \(0\)\
\-\ metabolic\\:\\ 0\\.029336359743942834\ \(0\)\
\-\ appreciated\\:\\ 0\\.029175032923848952\ \(0\)\
\-\ caucasian\\:\\ 0\\.028765994961272273\ \(0\)\
\-\ leading\\:\\ 0\\.028765994961272273\ \(0\)\
\-\ painful\\:\\ 0\\.02861990248800179\ \(0\)\
\-\ bodies\\:\\ 0\\.028338541808676343\ \(0\)\
\-\ disc\\:\\ 0\\.02811428556642914\ \(0\)\
\-\ that\\:\\ 0\\.028086519673885143\ \(0\)\
\-\ light\\:\\ 0\\.028027007780408446\ \(0\)\
\-\ included\\:\\ 0\\.027983867312470906\ \(0\)\
\-\ thought\\:\\ 0\\.027941052436073324\ \(0\)\
\-\ wrist\\:\\ 0\\.027941052436073324\ \(0\)\
\-\ degenerative\\:\\ 0\\.02749025662648023\ \(0\)\
\-\ by\\:\\ 0\\.02748432235807994\ \(0\)\
\-\ disorder\\:\\ 0\\.027373284560838807\ \(0\)\
\-\ numerous\\:\\ 0\\.02733482377491131\ \(0\)\
\-\ sclerotic\\:\\ 0\\.027146336530073725\ \(0\)\
\-\ clinically\\:\\ 0\\.02689255230079889\ \(0\)\
\-\ under\\:\\ 0\\.026787169502099167\ \(0\)\
\-\ frequently\\:\\ 0\\.02664963684635087\ \(0\)\
\-\ absent\\:\\ 0\\.02654863220439239\ \(0\)\
\-\ another\\:\\ 0\\.02648228122351352\ \(0\)\
\-\ intermittent\\:\\ 0\\.026449394498398598\ \(0\)\
\-\ underlying\\:\\ 0\\.026416697323184118\ \(0\)\
\-\ relatively\\:\\ 0\\.02635186296955529\ \(0\)\
\-\ last\\:\\ 0\\.026319721556691978\ \(0\)\
\-\ arthritis\\:\\ 0\\.026319721556691978\ \(0\)\
\-\ be\\:\\ 0\\.026254752967457055\ \(0\)\
\-\ calcified\\:\\ 0\\.02606894286083578\ \(0\)\
\-\ best\\:\\ 0\\.026038360877366534\ \(0\)\
\-\ neurologic\\:\\ 0\\.02585825228356461\ \(0\)\
\-\ levels\\:\\ 0\\.025655107256763336\ \(0\)\
\-\ occurs\\:\\ 0\\.025514332187158113\ \(0\)\
\-\ tissues\\:\\ 0\\.025514332187158113\ \(0\)\
\-\ includes\\:\\ 0\\.02516387267308802\ \(0\)\
\-\ narrowing\\:\\ 0\\.02508598205547976\ \(0\)\
\-\ made\\:\\ 0\\.024958494798329168\ \(0\)\
\-\ symptomatic\\:\\ 0\\.02488335536612642\ \(0\)\
\-\ minimal\\:\\ 0\\.024687717213776366\ \(0\)\
\-\ change\\:\\ 0\\.024521899106776227\ \(0\)\
\-\ rare\\:\\ 0\\.02442927755227922\ \(0\)\
\-\ to\\:\\ 0\\.024270212656480397\ \(0\)\
\-\ effusion\\:\\ 0\\.024030234208558002\ \(0\)\
\-\ its\\:\\ 0\\.023945244690942485\ \(0\)\
\-\ commonly\\:\\ 0\\.023945244690942485\ \(0\)\
\-\ studies\\:\\ 0\\.023738179946056724\ \(0\)\
\-\ ap\\:\\ 0\\.02323272064786233\ \(0\)\
\-\ sclerosis\\:\\ 0\\.02304970657681637\ \(0\)\
\-\ identified\\:\\ 0\\.022942666718313718\ \(0\)\
\-\ left\\:\\ 0\\.022077770457668275\ \(0\)\
\-\ spine\\:\\ 0\\.02137732523643841\ \(0\)\
\-\ positive\\:\\ 0\\.02132393242634954\ \(0\)\
\-\ often\\:\\ 0\\.021115248880759305\ \(0\)\
\-\ patient\\:\\ 0\\.021050516824594783\ \(0\)\
\-\ differential\\:\\ 0\\.02102630952410374\ \(0\)\
\-\ aspect\\:\\ 0\\.020877012902657158\ \(0\)\
\-\ will\\:\\ 0\\.020828107908449793\ \(0\)\
\-\ examination\\:\\ 0\\.02070765870865417\ \(0\)\
\-\ approximately\\:\\ 0\\.02064837975552888\ \(0\)\
\-\ clinical\\:\\ 0\\.020508587609636583\ \(0\)\
\-\ some\\:\\ 0\\.020360935081577825\ \(0\)\
\-\ age\\:\\ 0\\.020316265998857157\ \(0\)\
\-\ only\\:\\ 0\\.020217028292863364\ \(0\)\
\-\ negative\\:\\ 0\\.020034187724920043\ \(0\)\
\-\ loss\\:\\ 0\\.01971522562827228\ \(0\)\
\-\ changes\\:\\ 0\\.019557359603088978\ \(0\)\
\-\ when\\:\\ 0\\.019547637331309233\ \(0\)\
\-\ level\\:\\ 0\\.019547637331309233\ \(0\)\
\-\ weeks\\:\\ 0\\.019394305181188124\ \(0\)\
\-\ likely\\:\\ 0\\.0193378575095365\ \(0\)\
\-\ head\\:\\ 0\\.019300535373636907\ \(0\)\
\-\ two\\:\\ 0\\.019217447643045515\ \(0\)\
\-\ secondary\\:\\ 0\\.019180906813357865\ \(0\)\
\-\ however\\:\\ 0\\.019153654827267295\ \(0\)\
\-\ if\\:\\ 0\\.01880227663806627\ \(0\)\
\-\ axial\\:\\ 0\\.01869261036119373\ \(0\)\
\-\ fluid\\:\\ 0\\.01868426165594154\ \(0\)\
\-\ common\\:\\ 0\\.01835213154132283\ \(0\)\
\-\ both\\:\\ 0\\.018045825341139476\ \(0\)\
\-\ over\\:\\ 0\\.017993881735113765\ \(0\)\
\-\ symptoms\\:\\ 0\\.017705853166620884\ \(0\)\
\-\ acute\\:\\ 0\\.01750581374052149\ \(0\)\
\-\ soft\\:\\ 0\\.017228061700100137\ \(0\)\
\-\ can\\:\\ 0\\.01698178505031307\ \(0\)\
\-\ other\\:\\ 0\\.016805346827289576\ \(0\)\
\-\ present\\:\\ 0\\.016605242988250748\ \(0\)\
\-\ but\\:\\ 0\\.01600233651255335\ \(0\)\
\-\ findings\\:\\ 0\\.015971223395104175\ \(0\)\
\-\ multiple\\:\\ 0\\.015828243335802787\ \(0\)\
\-\ male\\:\\ 0\\.014408156285309618\ \(0\)\
\-\ normal\\:\\ 0\\.01321259059960291\ \(0\)\
\-\ as\\:\\ 0\\.013000376524141353\ \(0\)\
\-\ there\\:\\ 0\\.012876157562742964\ \(0\)\
\-\ an\\:\\ 0\\.012374561031062626\ \(0\)\
\-\ history\\:\\ 0\\.012363598816646714\ \(0\)\
\-\ at\\:\\ 0\\.0122229848027059\ \(0\)\
\-\ pain\\:\\ 0\\.011579791337020195\ \(0\)\
\-\ this\\:\\ 0\\.011119663555451907\ \(0\)\
\-\ right\\:\\ 0\\.010728857226780533\ \(0\)\
\-\ no\\:\\ 0\\.010523278672547766\ \(0\)\
\-\ year\\:\\ 0\\.00997288062703614\ \(0\)\
\-\ for\\:\\ 0\\.009808230652010447\ \(0\)\
\-\ on\\:\\ 0\\.009773437876927412\ \(0\)\
